- Home
- GNLX vs ANVS Comparison
GNLX vs ANVS Comparison
Compare GNLX & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLX | ANVS |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 111.3M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GNLX | ANVS |
|---|---|---|
| Price | $4.20 | $3.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $19.75 | $13.50 |
| AVG Volume (30 Days) | 168.1K | ★ 1.5M |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $1.11 |
| 52 Week High | $8.54 | $5.60 |
Technical Indicators
Market Signals| Indicator | GNLX | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 35.89 | 48.80 |
| Support Level | $4.00 | $3.58 |
| Resistance Level | $4.75 | $4.05 |
| Average True Range (ATR) | 0.37 | 0.43 |
| MACD | -0.02 | -0.17 |
| Stochastic Oscillator | 13.07 | 6.43 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.